ADO and neoplasm: ADO is released in the neoplastic microenvironment either by CD73+ tumor cells or by CD73+ infiltrating leukocyte subsets, such as myeloid-derived suppressor cells (MDSC) or regulatory T cells (Treg) [4, 9, 10].